The patient was admitted with sudden myoclonus symptoms, sudden hypotonia observed. Further evaluation confirmed gene variant p.A467T and c.2157+5_6GC>AG. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with chronic sensory axonal neuropathy, chronic increased csf protein concentration condition. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent emg: myopathic abnormalities detected, moderate ragged-red muscle fibers manifestation, clinical signs of sudden dysphagia, severe myoclonus observed. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of episodic increased csf protein concentration. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of chronic infantile onset, history of intermittent increased csf protein concentration, presence of episodic dysphagia, intermittent hypotonia condition. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with dysphagia observed, history of acute infantile onset. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe infantile onset, chronic ragged-red muscle fibers detected. Further evaluation confirmed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive sensory axonal neuropathy, diagnosed with acute dysphagia. Further evaluation confirmed gene variant c.2243G>C p.Trp748Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of persistent ataxia. Further evaluation confirmed gene variant c.2243G>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of severe dysphagia, persistent myoclonus condition, episodic infantile onset observed, presence of progressive ragged-red muscle fibers. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of moderate sensory axonal neuropathy, presence of episodic ataxia, history of episodic external ophthalmoplegia. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild increased csf protein concentration condition. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of episodic ragged-red muscle fibers, hypotonia observed. Further evaluation confirmed gene variant c.2864A>G (p.Tyr955Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with episodic emg: myopathic abnormalities symptoms, moderate external ophthalmoplegia, acute hypotonia. Further evaluation confirmed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute myoclonus observed, diagnosed with sudden increased csf protein concentration. Further evaluation confirmed gene variant C752T (T251I) and C1760T (P587L). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive increased csf protein concentration, severe hypotonia manifestation, clinical signs of mild ataxia, diagnosed with moderate infantile onset. Further evaluation confirmed gene variant c3239G>C p.Ser1080Thr. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with episodic myoclonus symptoms, acute sensory axonal neuropathy detected, clinical signs of episodic dysphagia. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of acute myoclonus, history of moderate hypotonia, chronic external ophthalmoplegia. Further evaluation confirmed gene variant P765T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of ragged-red muscle fibers, persistent myoclonus manifestation. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of hypotonia, progressive myoclonus symptoms. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild sensory axonal neuropathy symptoms, severe increased csf protein concentration observed. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic myoclonus condition, diagnosed with chronic ataxia, acute dysphagia observed. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic myoclonus manifestation, sudden hypotonia observed. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent emg: myopathic abnormalities detected, history of progressive ragged-red muscle fibers, history of increased csf protein concentration. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of episodic ataxia. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with myoclonus, moderate hypotonia symptoms, history of persistent emg: myopathic abnormalities. Further evaluation confirmed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of moderate ataxia, presence of persistent emg: myopathic abnormalities, presence of chronic ragged-red muscle fibers, sensory axonal neuropathy condition. Further evaluation confirmed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden ragged-red muscle fibers. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive myoclonus manifestation, episodic hypotonia manifestation, mild emg: myopathic abnormalities symptoms. Further evaluation confirmed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent ataxia, moderate dysphagia, infantile onset observed. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of ragged-red muscle fibers, mild increased csf protein concentration detected, moderate ataxia symptoms, mild dysphagia detected. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of chronic emg: myopathic abnormalities, moderate increased csf protein concentration observed, intermittent sensory axonal neuropathy, presence of severe external ophthalmoplegia. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate external ophthalmoplegia, progressive dysphagia observed, clinical signs of mild ataxia. Further evaluation confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent dysphagia condition, chronic ataxia observed, progressive hypotonia. Further evaluation confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of progressive increased csf protein concentration, diagnosed with moderate external ophthalmoplegia, history of severe infantile onset. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with persistent dysphagia, chronic increased csf protein concentration observed, acute ataxia detected, diagnosed with sudden myoclonus. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent infantile onset observed, persistent sensory axonal neuropathy. Further evaluation confirmed gene variant c3239G>C p.Ser1080Thr. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of episodic myoclonus, severe external ophthalmoplegia observed, progressive ataxia observed, persistent sensory axonal neuropathy condition. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of episodic emg: myopathic abnormalities, presence of mild increased csf protein concentration, mild dysphagia observed. Further evaluation confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent ragged-red muscle fibers observed, sudden sensory axonal neuropathy condition, diagnosed with progressive hypotonia. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute ragged-red muscle fibers, presence of moderate sensory axonal neuropathy, mild ataxia condition. Further evaluation confirmed gene variant c.679C>T p.R227W and c.2542G>A p.G848S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe hypotonia symptoms, clinical signs of chronic infantile onset, sudden external ophthalmoplegia detected, moderate dysphagia observed. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of severe infantile onset, acute myoclonus. Further evaluation confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent ataxia condition. Further evaluation confirmed gene variant 1399G>A A467T and 3573G>T K1191N. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with infantile onset manifestation. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent emg: myopathic abnormalities manifestation, clinical signs of severe myoclonus, clinical signs of progressive ataxia, clinical signs of sudden dysphagia. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute myoclonus observed, presence of persistent emg: myopathic abnormalities, sudden external ophthalmoplegia observed. Further evaluation confirmed gene variant p.A467T and c.2157+5_6GC>AG. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of episodic external ophthalmoplegia. Further evaluation confirmed gene variant c.2243G>C p.Trp748Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of acute increased csf protein concentration, presence of episodic infantile onset, presence of emg: myopathic abnormalities. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent hypotonia observed. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with hypotonia, presence of severe infantile onset, sudden external ophthalmoplegia manifestation. Further evaluation confirmed gene variant 1868T>G  L623W and 2263A>G K755E. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe ataxia detected, history of persistent dysphagia. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with episodic hypotonia observed, intermittent ataxia, clinical signs of persistent emg: myopathic abnormalities. Further evaluation confirmed gene variant c.2243G>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of chronic external ophthalmoplegia, episodic infantile onset observed, hypotonia observed. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of moderate hypotonia, presence of intermittent ataxia. Further evaluation confirmed gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with sudden hypotonia, mild ataxia. Further evaluation confirmed gene variant c.2864A>G (p.Tyr955Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of severe increased csf protein concentration, sudden myoclonus condition. Further evaluation confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent infantile onset condition, persistent ataxia condition. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with intermittent dysphagia, moderate hypotonia observed, acute ataxia detected. Further evaluation confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of persistent external ophthalmoplegia, diagnosed with persistent ragged-red muscle fibers, intermittent dysphagia symptoms. Further evaluation confirmed gene variant p.Arg953Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with dysphagia detected, diagnosed with sudden hypotonia, mild increased csf protein concentration manifestation. Further evaluation confirmed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden sensory axonal neuropathy condition, moderate hypotonia manifestation, progressive ragged-red muscle fibers symptoms, severe myoclonus observed. Further evaluation confirmed gene variant p.A467T and c.2157+5_6GC>AG. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden increased csf protein concentration detected, intermittent sensory axonal neuropathy, progressive dysphagia. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute ragged-red muscle fibers observed, mild sensory axonal neuropathy condition, sudden dysphagia observed. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of acute hypotonia, persistent dysphagia observed. Further evaluation confirmed gene variant c.2864A>G (p.Tyr955Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent emg: myopathic abnormalities manifestation, history of progressive sensory axonal neuropathy, episodic infantile onset observed. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of moderate increased csf protein concentration, presence of severe hypotonia. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive emg: myopathic abnormalities, mild myoclonus condition, presence of infantile onset. Further evaluation confirmed gene variant 1399G >A A467T and 2243G >C W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive infantile onset observed, diagnosed with severe dysphagia, history of mild increased csf protein concentration, mild hypotonia condition. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with progressive sensory axonal neuropathy, acute increased csf protein concentration, intermittent external ophthalmoplegia symptoms. Further evaluation confirmed gene variant c3239G>C p.Ser1080Thr. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute dysphagia. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of sudden external ophthalmoplegia, increased csf protein concentration observed, progressive ragged-red muscle fibers detected, episodic sensory axonal neuropathy symptoms. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of moderate emg: myopathic abnormalities, chronic ragged-red muscle fibers, history of moderate sensory axonal neuropathy. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent dysphagia condition, episodic ragged-red muscle fibers detected, episodic myoclonus detected, persistent hypotonia detected. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild infantile onset observed, history of moderate ataxia, episodic ragged-red muscle fibers detected, clinical signs of severe myoclonus. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ataxia condition. Further evaluation confirmed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate emg: myopathic abnormalities observed, ragged-red muscle fibers. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of chronic ragged-red muscle fibers, acute myoclonus detected. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with emg: myopathic abnormalities, diagnosed with increased csf protein concentration, external ophthalmoplegia. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate increased csf protein concentration manifestation, sudden ragged-red muscle fibers symptoms, chronic ataxia manifestation. Further evaluation confirmed gene variant p.A467T and c.2157+5_6GC>AG. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with infantile onset condition, diagnosed with persistent sensory axonal neuropathy, sudden dysphagia observed, clinical signs of mild hypotonia. Further evaluation confirmed gene variant c.1535A>T p.K512M. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of dysphagia, persistent sensory axonal neuropathy detected, intermittent infantile onset manifestation, moderate emg: myopathic abnormalities manifestation. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with increased csf protein concentration condition, presence of sudden hypotonia, chronic dysphagia manifestation, clinical signs of acute ragged-red muscle fibers. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe hypotonia manifestation, persistent myoclonus observed. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with external ophthalmoplegia, presence of severe ataxia. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent sensory axonal neuropathy observed, clinical signs of external ophthalmoplegia, progressive ragged-red muscle fibers, persistent ataxia detected. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent external ophthalmoplegia, infantile onset condition. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ataxia manifestation, history of chronic sensory axonal neuropathy. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with hypotonia observed, history of acute infantile onset, progressive ataxia observed. Further evaluation confirmed gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of episodic infantile onset, history of mild ragged-red muscle fibers, mild sensory axonal neuropathy observed, presence of intermittent hypotonia. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of severe ataxia, episodic dysphagia symptoms. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of mild myoclonus, persistent sensory axonal neuropathy. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ragged-red muscle fibers detected. Further evaluation confirmed gene variant c. 2243G>C (p. W748S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute external ophthalmoplegia, presence of mild myoclonus. Further evaluation confirmed gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent ragged-red muscle fibers detected. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of acute myoclonus. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic sensory axonal neuropathy. Further evaluation confirmed gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with persistent increased csf protein concentration symptoms, hypotonia condition, presence of progressive myoclonus. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic myoclonus detected, clinical signs of acute infantile onset, mild sensory axonal neuropathy condition, clinical signs of sudden external ophthalmoplegia. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of mild increased csf protein concentration, presence of intermittent ragged-red muscle fibers, history of mild myoclonus. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with progressive dysphagia. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ragged-red muscle fibers manifestation, chronic increased csf protein concentration observed, episodic hypotonia condition, progressive myoclonus detected. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with moderate infantile onset, history of severe increased csf protein concentration, moderate hypotonia detected. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with ragged-red muscle fibers observed. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with episodic sensory axonal neuropathy, diagnosed with chronic myoclonus, chronic dysphagia observed. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate dysphagia observed, presence of severe ragged-red muscle fibers, presence of severe infantile onset, severe hypotonia symptoms. Further evaluation confirmed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of mild emg: myopathic abnormalities, clinical signs of progressive infantile onset, chronic ataxia manifestation. Further evaluation confirmed gene variant c3239G>C p.Ser1080Thr. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with chronic dysphagia, mild sensory axonal neuropathy detected, diagnosed with sudden ataxia. Further evaluation confirmed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of sudden increased csf protein concentration, episodic external ophthalmoplegia detected, history of hypotonia. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent myoclonus detected, presence of acute ataxia. Further evaluation confirmed gene variant p.Arg953Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of acute dysphagia, moderate ataxia observed, chronic infantile onset detected. Further evaluation confirmed gene variant P765T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic sensory axonal neuropathy manifestation. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of sudden emg: myopathic abnormalities, moderate dysphagia condition, presence of severe ataxia. Further evaluation confirmed gene variant c3239G>C p.Ser1080Thr. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of persistent ragged-red muscle fibers, chronic hypotonia observed. Further evaluation confirmed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with external ophthalmoplegia, history of acute increased csf protein concentration, diagnosed with chronic hypotonia, infantile onset symptoms. Further evaluation confirmed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ataxia condition, sudden hypotonia observed, chronic dysphagia detected. Further evaluation confirmed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute dysphagia symptoms, mild myoclonus symptoms, episodic increased csf protein concentration. Further evaluation confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate dysphagia observed, history of acute ragged-red muscle fibers, mild myoclonus. Further evaluation confirmed gene variant P765T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of chronic emg: myopathic abnormalities, chronic myoclonus symptoms. Further evaluation confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of dysphagia, severe myoclonus symptoms, mild hypotonia manifestation. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with severe emg: myopathic abnormalities, persistent increased csf protein concentration manifestation, severe external ophthalmoplegia symptoms. Further evaluation confirmed gene variant 1399G>A A467T and 3573G>T K1191N. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of progressive emg: myopathic abnormalities. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of severe dysphagia, chronic ragged-red muscle fibers detected, moderate hypotonia manifestation. Further evaluation confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with chronic hypotonia, mild dysphagia observed, diagnosed with mild myoclonus, intermittent infantile onset. Further evaluation confirmed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with dysphagia detected, sudden emg: myopathic abnormalities detected, hypotonia observed, presence of progressive ragged-red muscle fibers. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive myoclonus detected, presence of episodic hypotonia, acute infantile onset manifestation, sudden ragged-red muscle fibers. Further evaluation confirmed gene variant c.1535A>T p.K512M. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of acute external ophthalmoplegia, episodic myoclonus symptoms. Further evaluation confirmed gene variant c.679C>T p.R227W and c.2542G>A p.G848S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic hypotonia condition, diagnosed with episodic external ophthalmoplegia, intermittent increased csf protein concentration observed. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with episodic external ophthalmoplegia condition, diagnosed with moderate ataxia, severe myoclonus, mild infantile onset condition. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic ragged-red muscle fibers detected, diagnosed with episodic infantile onset, clinical signs of persistent ataxia, acute external ophthalmoplegia manifestation. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute increased csf protein concentration condition, diagnosed with intermittent ataxia, presence of progressive external ophthalmoplegia, infantile onset manifestation. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent infantile onset symptoms, intermittent ataxia, chronic myoclonus symptoms. Further evaluation confirmed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive emg: myopathic abnormalities, increased csf protein concentration manifestation, chronic myoclonus observed. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with chronic ragged-red muscle fibers, clinical signs of sudden emg: myopathic abnormalities, presence of progressive ataxia. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe infantile onset detected, episodic external ophthalmoplegia condition. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe hypotonia, sudden myoclonus observed, external ophthalmoplegia symptoms. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild ataxia observed, ragged-red muscle fibers condition, sudden emg: myopathic abnormalities condition, acute hypotonia observed. Further evaluation confirmed gene variant P765T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic ragged-red muscle fibers observed, chronic sensory axonal neuropathy observed, ataxia detected, external ophthalmoplegia. Further evaluation confirmed gene variant c.1535A>T p.K512M. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of sudden infantile onset, clinical signs of sudden hypotonia. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of persistent ataxia, external ophthalmoplegia, episodic ragged-red muscle fibers symptoms. Further evaluation confirmed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild myoclonus observed, progressive infantile onset condition, presence of acute sensory axonal neuropathy, mild ataxia detected. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of emg: myopathic abnormalities, intermittent dysphagia manifestation, severe ataxia condition, hypotonia. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent emg: myopathic abnormalities symptoms, persistent dysphagia detected, progressive external ophthalmoplegia, progressive ragged-red muscle fibers symptoms. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute external ophthalmoplegia condition, diagnosed with episodic sensory axonal neuropathy, presence of sudden dysphagia, diagnosed with chronic ragged-red muscle fibers. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with external ophthalmoplegia, severe myoclonus detected, sudden sensory axonal neuropathy condition, diagnosed with increased csf protein concentration. Further evaluation confirmed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 − 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate hypotonia observed, diagnosed with severe emg: myopathic abnormalities, mild dysphagia observed, history of severe ataxia. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of progressive sensory axonal neuropathy. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic sensory axonal neuropathy detected, severe myoclonus manifestation. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden ragged-red muscle fibers, episodic infantile onset symptoms, persistent myoclonus condition. Further evaluation confirmed gene variant p.A467T and c.2157+5_6GC>AG. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic increased csf protein concentration detected. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute external ophthalmoplegia symptoms, clinical signs of sudden ragged-red muscle fibers, presence of moderate ataxia. Further evaluation confirmed gene variant (c.2542G > A) p.G848S and (c.1399G > A) p.A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of ragged-red muscle fibers, persistent external ophthalmoplegia observed. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with hypotonia detected, sudden infantile onset detected, persistent emg: myopathic abnormalities condition. Further evaluation confirmed gene variant p.Arg953Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with emg: myopathic abnormalities condition. Further evaluation confirmed gene variant p.Arg627Gln and p.Arg852Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of acute external ophthalmoplegia, clinical signs of severe myoclonus, diagnosed with emg: myopathic abnormalities. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of moderate external ophthalmoplegia. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden sensory axonal neuropathy condition. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe dysphagia observed, clinical signs of mild external ophthalmoplegia. Further evaluation confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of episodic hypotonia, severe sensory axonal neuropathy. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of increased csf protein concentration, episodic external ophthalmoplegia symptoms, history of sudden dysphagia. Further evaluation confirmed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with emg: myopathic abnormalities symptoms, sudden sensory axonal neuropathy detected, intermittent external ophthalmoplegia observed. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden infantile onset manifestation, severe increased csf protein concentration symptoms, episodic sensory axonal neuropathy manifestation, chronic ataxia observed. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden hypotonia detected, clinical signs of mild myoclonus, progressive dysphagia detected. Further evaluation confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with external ophthalmoplegia manifestation, episodic ataxia symptoms, mild emg: myopathic abnormalities symptoms, presence of intermittent sensory axonal neuropathy. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute myoclonus detected, severe hypotonia condition. Further evaluation confirmed gene variant c.2243G>C p.Trp748Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of sudden myoclonus, acute sensory axonal neuropathy condition, persistent external ophthalmoplegia symptoms, clinical signs of moderate dysphagia. Further evaluation confirmed gene variant A467T and W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive ataxia symptoms, persistent ragged-red muscle fibers symptoms, history of mild external ophthalmoplegia. Further evaluation confirmed gene variant c.3102delG (p.Lys1035Serfs*59) and c.3286C>T (p.Arg1096Cys). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of intermittent external ophthalmoplegia, clinical signs of intermittent sensory axonal neuropathy, history of severe hypotonia. Further evaluation confirmed gene variant 1399G→A (A467T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with sudden myoclonus observed, presence of progressive increased csf protein concentration, episodic emg: myopathic abnormalities detected. Further evaluation confirmed gene variant c.2584G>A p.A862T and c.830A>T p.H277L. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe sensory axonal neuropathy observed, persistent hypotonia observed. Further evaluation confirmed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with severe sensory axonal neuropathy, diagnosed with chronic external ophthalmoplegia, severe increased csf protein concentration symptoms, diagnosed with acute hypotonia. Further evaluation confirmed gene variant c.1156C>T p.R386C and c.2794C>T p.H932Y. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate ragged-red muscle fibers detected. Further evaluation confirmed gene variant 1399G>A A467T and 3573G>T K1191N. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with infantile onset manifestation, hypotonia symptoms, history of persistent sensory axonal neuropathy, chronic external ophthalmoplegia. Further evaluation confirmed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with severe emg: myopathic abnormalities, intermittent sensory axonal neuropathy symptoms, history of severe external ophthalmoplegia, diagnosed with sudden myoclonus. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with acute external ophthalmoplegia symptoms. Further evaluation confirmed gene variant Tyr955Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with chronic infantile onset, presence of intermittent sensory axonal neuropathy, ataxia symptoms, history of increased csf protein concentration. Further evaluation confirmed gene variant A467T. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of persistent ataxia. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic increased csf protein concentration condition, moderate ataxia symptoms, severe sensory axonal neuropathy. Further evaluation confirmed gene variant W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with severe emg: myopathic abnormalities observed. Further evaluation confirmed gene variant R853W and G737R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of severe myoclonus, intermittent infantile onset symptoms, history of persistent hypotonia. Further evaluation confirmed gene variant 1399G >A A467T and 2243G >C W748S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive infantile onset, progressive emg: myopathic abnormalities condition, persistent hypotonia observed. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate infantile onset symptoms, episodic sensory axonal neuropathy. Further evaluation confirmed gene variant Tyr955Cys. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with diagnosed with infantile onset, clinical signs of sensory axonal neuropathy. Further evaluation confirmed gene variant c.1156C>T p.R386C and c.2794C>T p.H932Y. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with intermittent ragged-red muscle fibers manifestation, clinical signs of progressive infantile onset. Further evaluation confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with episodic ataxia detected, acute increased csf protein concentration detected, presence of progressive emg: myopathic abnormalities. Further evaluation confirmed gene variant W748S and c.3643+2T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with moderate hypotonia. Further evaluation confirmed gene variant c. 2243G>C (p. W748S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with emg: myopathic abnormalities manifestation, clinical signs of hypotonia. Further evaluation confirmed gene variant C752T (T251I) and C1760T (P587L). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of severe external ophthalmoplegia, presence of mild infantile onset. Further evaluation confirmed gene variant c.1288A>T and c.2752T>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with dysphagia condition, moderate myoclonus observed, moderate emg: myopathic abnormalities symptoms. Further evaluation confirmed gene variant c.2243G>C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic dysphagia observed, moderate external ophthalmoplegia condition, diagnosed with persistent hypotonia, mild emg: myopathic abnormalities symptoms. Further evaluation confirmed gene variant c.679C>T p.R227W and c.2542G>A p.G848S. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of acute myoclonus, moderate hypotonia detected. Further evaluation confirmed gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of progressive external ophthalmoplegia, history of episodic dysphagia, intermittent ragged-red muscle fibers manifestation. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with clinical signs of chronic external ophthalmoplegia, severe emg: myopathic abnormalities detected. Further evaluation confirmed . The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with presence of persistent external ophthalmoplegia. Further evaluation confirmed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with chronic infantile onset symptoms, history of sudden ragged-red muscle fibers. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild emg: myopathic abnormalities symptoms, presence of mild dysphagia. Further evaluation confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with mild ragged-red muscle fibers condition, mild dysphagia detected. Further evaluation confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with ataxia manifestation, episodic ragged-red muscle fibers manifestation, presence of sudden myoclonus. Further evaluation confirmed gene variant p.W748S and p.T914P. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with progressive myoclonus observed, diagnosed with moderate sensory axonal neuropathy, episodic ragged-red muscle fibers. Further evaluation confirmed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
The patient was admitted with history of chronic hypotonia, myoclonus condition, clinical signs of mild ataxia, history of chronic ragged-red muscle fibers. Further evaluation confirmed gene variant T251I/P587L and R807C. The clinical course indicated ongoing deterioration, and therapeutic interventions were tailored to address the specific neurological and muscular deficits.
